| P50 | author | Rose-Mary Boustany | Q87803798 |
| P2093 | author name string | Joelle Makoukji | |
| | Nadine J Makhoul | |
| | Hayat Harati | |
| | Jihane Soueid | |
| | Sally El-Sitt | |
| | Jamal Al Ali | |
| P2860 | cites work | A galactosylceramide binding domain is involved in trafficking of CLN3 from Golgi to rafts via recycling endosomes | Q24298716 |
| | Mammalian Lass6 and its related family members regulate synthesis of specific ceramides | Q24299822 |
| | Ceramide synthases at the centre of sphingolipid metabolism and biology | Q24609859 |
| | An Overview of Sphingolipid Metabolism: From Synthesis to Breakdown | Q24628769 |
| | The sphingolipid salvage pathway in ceramide metabolism and signaling | Q24642219 |
| | Association of the Golgi UDP-galactose transporter with UDP-galactose:ceramide galactosyltransferase allows UDP-galactose import in the endoplasmic reticulum | Q24682498 |
| | Role for mammalian neutral sphingomyelinase 2 in confluence-induced growth arrest of MCF7 cells | Q28253449 |
| | Principles of bioactive lipid signalling: lessons from sphingolipids | Q28265743 |
| | CLN3p impacts galactosylceramide transport, raft morphology, and lipid content | Q28271390 |
| | Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors | Q28509468 |
| | Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas | Q30492014 |
| | Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species | Q30616090 |
| | Ceramides and cardiac function in children with chronic kidney disease. | Q33797077 |
| | Ceramide and apoptosis | Q33985377 |
| | Apoptosis and neurologic disease | Q34051306 |
| | Differential expression of (dihydro)ceramide synthases in mouse brain: oligodendrocyte-specific expression of CerS2/Lass2. | Q34694983 |
| | Apoptosis and caspases in neurodegenerative diseases | Q35097801 |
| | Hepatic fatty acid uptake is regulated by the sphingolipid acyl chain length. | Q35522279 |
| | Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease | Q35555867 |
| | Distinct roles for ceramide and glucosylceramide at different stages of neuronal growth | Q63761924 |
| | Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease) | Q68057216 |
| | Upregulation of Bcl-2 and elevation of ceramide in Batten disease | Q73339869 |
| | Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth | Q78358538 |
| | Ceramide is upregulated and associated with mortality in patients with chronic heart failure | Q86879019 |
| | Liquid Chromatography-High Resolution Mass Spectrometry Method to Study Sphingolipid Metabolism Changes in Response to CD95L | Q89899775 |
| | Association between CLN3 (Neuronal Ceroid Lipofuscinosis, CLN3 Type) Gene Expression and Clinical Characteristics of Breast Cancer Patients | Q36147348 |
| | Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II. | Q36149981 |
| | Neurology of the neuronal ceroid-lipofuscinoses: late infantile and juvenile types | Q36228299 |
| | The role of the ceramide acyl chain length in neurodegeneration: involvement of ceramide synthases | Q37760852 |
| | Juvenile neuronal ceroid lipofuscinoses | Q37992901 |
| | Ceramide function in the brain: when a slight tilt is enough. | Q38021345 |
| | Juvenile neuronal ceroid lipofuscinosis and education | Q38087457 |
| | Lysosomal storage diseases--the horizon expands | Q38128478 |
| | Men and mice: Relating their ages | Q38643990 |
| | CLN5 and CLN8 protein association with ceramide synthase: biochemical and proteomic approaches. | Q39243050 |
| | Transbilayer movement of ceramide in the plasma membrane of live cells | Q40123121 |
| | Cell death pathways in juvenile Batten disease | Q40375734 |
| | Ceramide: an intracellular signal for apoptosis | Q40497600 |
| | The sphingomyelin cycle and the second messenger function of ceramide. | Q40713913 |
| | CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide | Q40962723 |
| | NCL diseases - clinical perspectives | Q42048359 |
| | Bipotential roles of ceramide in the growth of hippocampal neurons: promotion of cell survival and dendritic outgrowth in dose- and developmental stage-dependent manners | Q42453723 |
| | Role of glycolipids in lipid rafts: a view through atomistic molecular dynamics simulations with galactosylceramide | Q43055743 |
| | The CLN3 gene is a novel molecular target for cancer drug discovery. | Q43878473 |
| | Traumatic injury induced homer-1a gene expression in cultured cortical neurons of rat. | Q46640533 |
| | Ceramide and its interconvertible metabolite sphingosine function as indispensable lipid factors involved in survival and dendritic differentiation of cerebellar Purkinje cells. | Q47903492 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ceramides | Q424213 |
| P304 | page(s) | 128 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Frontiers in Neurology | Q15817039 |
| P1476 | title | Developmental Comparison of Ceramide in Wild-Type and Mouse Brains and Sera | |
| P478 | volume | 10 | |